During the past decade, Great Lakes Clinical Trials conducted 68 clinical trials. In the 10-year time frame, 68 clinical trials started and 26 clinical trials were completed, i.e. on average, 38.2% percent of trials that started reached the finish line to date. In the past 5 years, 38 clinical trials started and 25 clinical trials were completed. i.e. 65.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Great Lakes Clinical Trials" #1 sponsor was "Midwest Center for Metabolic and Cardiovascular Research" with 8 trials, followed by "Eli Lilly and Company" with 6 trials sponsored, "Pfizer" with 6 trials sponsored, "Janssen Research & Development, LLC" with 5 trials sponsored and "Abbott Nutrition" with 5 trials sponsored. Other sponsors include 34 different institutions and companies that sponsored additional 34 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Great Lakes Clinical Trials" #1 collaborator was "National Institute on Aging (NIA)" with 2 trials as a collaborator, "ACH Food Companies, Inc." with 1 trials as a collaborator, "AbCellera Biologics Inc." with 1 trials as a collaborator, "Alzheimer's Disease Cooperative Study (ADCS)" with 1 trials as a collaborator and "Alzheimer's Therapeutic Research Institute" with 1 trials as a collaborator. Other collaborators include 16 different institutions and companies that were collaborators in the rest 26 trials.

According to Clinical.Site data, the most researched conditions in "Great Lakes Clinical Trials" are "Alzheimer Disease" (7 trials), "COVID-19" (7 trials), "Depressive Disorder, Major" (5 trials), "Mild Cognitive Impairment" (3 trials) and "Adjunctive Treatment of Major Depressive Disorder" (2 trials). Many other conditions were trialed in "Great Lakes Clinical Trials" in a lesser frequency.

Most popular intervention types in "Great Lakes Clinical Trials" are "Drug" (44 trials), "Other" (23 trials), "Biological" (13 trials), "Dietary Supplement" (3 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (33 trials), "Rapastinel" (3 trials), "Remdesivir" (3 trials), "Baricitinib" (2 trials) and "Guselkumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Great Lakes Clinical Trials" are 66 trials for "All" genders and 2 trials for "Female" genders.

Currently, there are NaN active trials in "Great Lakes Clinical Trials". undefined are not yet recruiting, 8 are recruiting, 7 are Active, not recruiting, and 2 are Enrolling by invitation. In total, there were 42 completed trials in Great Lakes Clinical Trials, 1 suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in Great Lakes Clinical Trials, 2 "Phase 1" clinical trials were conducted, 24 "Phase 2" clinical trials and 27 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 3 trials, and there were also 15 trials that are defined as “Not Applicable".